Early stage adenocarcinoma of cervix with ovarian micrometastasis
نویسندگان
چکیده
منابع مشابه
Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
BACKGROUND In cervical adenocarcinoma, surgical treatment involves bilateral oophorectomy, which affects the long-term quality of life. The aim of our study was to access the incidence of ovarian metastasis in early-stage cervical adenocarcinoma and to suggest an algorithm for the triage of these patients to preserve the ovaries. MATERIAL AND METHODS A total 101 patients with cervical adenocarc...
متن کاملOvarian preservation in adenocarcinoma of the uterine cervix
BACKGROUND An upward trending incidence in cervical adenocarcinoma (ADC) has been reported in many countries. Because non-squamous histology has been associated with increased risk of ovarian metastases (OM), bilateral oophorectomy is commonly performed for ADC without due consideration for ovarian preservation, degrading the quality of life for young premenopausal patients. METHODS Subjects ...
متن کاملAdenocarcinoma of the cervix.
With the impact of screening programmes in reducing the incidence of squamous carcinoma of the cervix it is timely that attention is concentrated on glandular lesions. There is convincing evidence that adenocarcinoma of the cervix is increasing in incidence, and this may be related to either oral contraceptive use, human papillovirus infections, or both. Compared to its squamous cancer counterp...
متن کاملTreatment of early-stage esophageal adenocarcinoma.
Although T2,N0,M0 esophageal adenocarcinoma is grouped with other locoregional disease by NCCN, no consensus exists about how it should be treated. One of the inherent complexities of treating T2,N0,M0 esophageal adenocarcinoma is the inaccuracy of the clinical staging. In addition, conflicting evidence exists about whether neoadjuvant therapy adds any benefit to esophagectomy. A 52-year-old pa...
متن کاملDetection of early-stage pancreatic adenocarcinoma.
BACKGROUND Pancreatic adenocarcinoma is an almost universally lethal disease, in large part, due to our inability to detect early-stage disease. Monoclonal antibody PAM4 is reactive with a unique biomarker expressed by >85% of pancreatic adenocarcinomas. In this report, we examined the ability of a PAM4-based immunoassay to detect early-stage disease. MATERIALS AND METHODS The PAM4-based immu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Mid-life Health
سال: 2017
ISSN: 0976-7800
DOI: 10.4103/jmh.jmh_52_17